Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Conceptus to Hold 2006 Fourth Quarter Financial Results / 2007 Financial Guidance Conference Call February 27, 2006.


MOUNTAIN VIEW, Calif. -- Conceptus conceptus /con·cep·tus/ (-tus) the product of the union of oocyte and spermatozoon at any stage of development from fertilization until birth, including extraembryonic membranes as well as the embryo or fetus. , Inc. (Nasdaq:CPTS CPTS Certified Penetration Testing Specialist (network security)
CPTS Comptroller Squadron
CPTS Computer Program Test Specifications
CPTS Catastrophe Personnel Tracking System
CPTS Claims Procedure Training Specialist
), developer of the Essure[R] procedure, the first and only non-incisional permanent birth control method available, today announced that the Company will release 2006 fourth quarter financial results on Tuesday, February 27, 2007 after the close of market. Management will host an investment community conference call beginning at 4:30 p.m. Eastern Time on February 27 to discuss the results and to answer questions. At that time, management will provide additional comments to the financial guidance for calendar year 2007 issued on February 5, 2007.

To participate in the live call by telephone, please dial (888) 803-8296 from the U.S., or for international callers, please dial (706) 634-1250. Individuals interested in listening to the live conference call via the Internet may do so by logging on to the Company's website, www.conceptus.com. A replay will be available on the website for 14 days.

A telephone replay will be available from 6:30 p.m. Eastern Time February 27, 2007 through 11:59 p.m. Eastern Time on March 1, 2007 by dialing (800) 642-1687 (domestic) or (706) 645-9291 (international) and entering conference ID number 9317795.

About the Essure Procedure

The Essure procedure, approved by the FDA FDA
abbr.
Food and Drug Administration


FDA,
n.pr See Food and Drug Administration.

FDA,
n.pr the abbreviation for the Food and Drug Administration.
 in 2002, deploys a soft micro-insert into the fallopian tube fallopian tube (fəlō`pēən), either of a pair of tubes extending from the uterus to the paired ovaries in the human female, also called oviducts, technically known as the uterine tube.  through the cervix using a minimally invasive transcervical tubal Tubal (t`bəl), in the Bible, son of Japheth.  access catheter. Once in place, the device is designed to elicit tissue growth in and around the micro-insert to form an occlusion occlusion /oc·clu·sion/ (o-kloo´zhun)
1. obstruction.

2. the trapping of a liquid or gas within cavities in a solid or on its surface.

3.
 or blockage in the fallopian tube. An Essure procedure does not require cutting or penetrating the abdomen and can be performed in a less costly procedure setting without general anesthesia Anesthesia, General Definition

General anesthesia is the induction of a state of unconsciousness with the absence of pain sensation over the entire body, through the administration of anesthetic drugs.
. A woman is able to return home about 45 minutes after the procedure is completed. There is a three-month waiting period after the procedure during which women must use another form of birth control. The Essure procedure is 99.80% effective (based on four years of follow-up data). The Essure procedure has been demonstrated in a small portion of the women undergoing clinical studies to be 99.74% effective (based on 5 years of follow-up data). Five-year follow-up of all patients in clinical trials is ongoing.

About Conceptus

Conceptus, Inc. manufactures and markets the Essure Permanent Birth Control system, an innovative medical device and procedure designed to provide a non-incisional alternative to tubal ligation ligation /li·ga·tion/ (li-ga´shun) the application of a ligature.

tubal ligation  sterilization of the female by constricting, severing, or crushing the uterine tubes.
, which is currently the leading form of birth control worldwide. The availability of the Essure procedure in the U.S. is expected to open up a market currently occupied by incisional tubal ligation and vasectomy vasectomy, male sterilization by surgical excision of the vas deferens, the thin duct that carries sperm cells from the testicles to the prostate and the penis. , which combined account for more than 1 million procedures annually.

Additional information about the Essure procedure is available at www.essure.com or by calling the Essure Information Center at 1-877-ESSURE1. Additional information about Conceptus is available at www.conceptus.com or by calling 1-877-ESSURE2.
COPYRIGHT 2007 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2007, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Feb 15, 2007
Words:471
Previous Article:Deltic Timber Corporation Elects New Board Members.
Next Article:Buffalo Wild Wings, Inc. Announces Fourth Quarter 2006 Results.
Topics:



Related Articles
Conceptus Reports Fourth Quarter and Year-End Financial Results.
Conceptus to Hold 2005 Fourth Quarter Financial Results/2006 Financial Guidance Conference Call February 15, 2006.
Conceptus Reports Record $10 Million Second Quarter Net Sales; Sets new highs for physician training; Increases 2006 guidance.
Conceptus Third Quarter Net Sales Double.
Wright Medical Group, Inc. Hosts Financial Guidance Conference Call.
Conceptus Updates 2006 Financial Guidance, Introduces 2007 Guidance.
Aspect Medical Systems, Inc. Reports Operating Results for Fourth Quarter and Year Ended December 31, 2006.
Endologix to Hold 2006 Fourth Quarter and Year End Financial Results Conference Call on February 22.
Wright Medical Group, Inc. Reports Results for Fourth Quarter Ended December 31, 2006.
Conceptus Reports First Quarter Financial Results.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles